Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

Quercetin effectively treated and prevented hair loss in mice.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Personality traits and anxiety affect hair loss patients' quality of life.

Regulatory T cells are essential for normal and improved wound healing in mice.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Low vitamin D can worsen pediatric alopecia areata.

Methotrexate with corticosteroids can effectively treat severe alopecia areata but often requires long-term maintenance.

The combined therapy was effective and safe for children with severe alopecia areata.

Lupus can look like hair loss from alopecia areata but needs different treatment.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Methylprednisolone pulse therapy works best for recent and specific types of severe alopecia areata.

Early recognition and treatment of Peripheral Arterial Disease is crucial to improve survival and health outcomes.

Some children and young adults with eyebrow and eyelash hair loss actually have a hair-pulling disorder, often with related psychological issues.

Azelaic acid and anthralin are similarly effective for treating patchy hair loss.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

New treatments like JAK inhibitors show promise for reversing alopecia areata.